Dr. Gloria Gaupmann
ROSA consult
Picture: Dr. Gloria Gaupmann
Symposia
Conference room: Forum 1
The EU Commission positively surprised the industry in spring 2024 by launching a counterpart to the US Biotech and Biomanufacturing Initiative. The EU Biotech Act is now due to come in 2026. What can this act do for the industry? What should the Act encompass in order warrant that Europe stays competitive with biotechnology?